Wednesday 28 February 2024
Salisbury Foundation Trust

FOI_7170

Internal Reference Number: FOI_7170

Date Request Received: 10/05/2023 00:00:00

Date Request Replied To: 16/05/2023 00:00:00

This response was sent via: By Email

Request Summary: intra-vitreal injections or implants

Request Category: Companies



 
Question Number 1:
1. How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2023:

• Aflibercept

• Bevacizumab

• Brolucizumab

• Dexamethasone

• Faricimab

• Fluocinolone acetonide

• Ranibizumab - Lucentis

• Ranibizumab – Ongavia

• Ranibizumab – Byooviz

• Ranibizumab - Ximluci
 
Answer To Question 1:
Aflibercept 1350
Bevacizumab 8
Brolucizumab 0
Dexamethasone 10
Faricimab 634
Fluocinolone acetonide 0
Ranibizumab - Lucentis 11
Ranibizumab - Ongavia 0
Ranibizumab - Byooviz 0
Ranibizumab - Ximluci 0
 
Question Number 2:
Please see attached form
 
Answer To Question 2:
See attached spreadsheet.

To accompany this answer to question 2 please also see the documents listed below:

 7170 FOI Q2 answers.xlsx
Please see Attachments:
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury NHS Foundation Trust
Trust Values